NANOBIOTIX : new translational data presented at ASTRO, NCI AND SITC’S Immunotherapy Workshop – Nasdaq
|
NANOBIOTIX : new translational data presented at ASTRO, NCI AND SITC'S Immunotherapy Workshop
Nasdaq Paris, France and Cambridge, Massachusetts (USA), June 15, 2017- NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today presented new … |
